Dexco Gestione
Criteri Gestione verificati 1/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Raul Guaragna
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | no data |
| Proprietà del CEO | n/a |
| Durata media del management | Nessun dato |
| Durata media del Consiglio di amministrazione | 7.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Articolo di analisi • May 18
Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...
Aggiornamento della narrazione • May 02
DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook
Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.
Aggiornamento della narrazione • Apr 18
DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside
Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.Aggiornamento della narrazione • Apr 04
DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook
Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.
Aggiornamento della narrazione • Mar 21
DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside
Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.Aggiornamento della narrazione • Mar 06
DXCO3: Planned Stock Split Will Support Positive Long Term Outlook
Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Aggiornamento della narrazione • Feb 20
DXCO3: Future Stock Split Will Support A More Attractive Share Repricing
Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Aggiornamento della narrazione • Feb 06
DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside
Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.Aggiornamento della narrazione • Jan 23
DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook
Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).Articolo di analisi • Jan 23
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Aggiornamento della narrazione • Jan 08
DXCO3: Future Margins And Stock Split Plan Will Support Upside
Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.Articolo di analisi • Dec 25
Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar
With a price-to-earnings (or "P/E") ratio of 41.1x Dexco S.A. ( BVMF:DXCO3 ) may be sending very bearish signals at the...Aggiornamento della narrazione • Dec 23
DXCO3: Stronger Future Margins And Investor Day May Drive Upside
Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.Articolo di analisi • Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...Articolo di analisi • Oct 06
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Aggiornamento della narrazione • Sep 06
Urbanization Trends And Digital Platforms Will Expand Market Reach
With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.Articolo di analisi • Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...Articolo di analisi • Mar 15
Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Dexco S.A. ( BVMF:DXCO3 ) filed its full-year result this time last week. The...
Nuova narrazione • Mar 10
New Ceramic Tiles Factory In Botucatu Will Improve Future Operations
Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.Articolo di analisi • Feb 12
Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Articolo di analisi • Dec 20
Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?
While Dexco S.A. ( BVMF:DXCO3 ) might not have the largest market cap around , it saw significant share price movement...Articolo di analisi • Dec 02
There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price
When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 8x, you may consider Dexco...Articolo di analisi • Oct 26
Is Dexco (BVMF:DXCO3) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • Aug 10
Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results
Shareholders of Dexco S.A. ( BVMF:DXCO3 ) will be pleased this week, given that the stock price is up 12% to R$8.05...Articolo di analisi • Aug 08
Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a decent share price growth of 14% on the...Articolo di analisi • Jul 19
Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Articolo di analisi • May 13
Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts
Last week saw the newest quarterly earnings release from Dexco S.A. ( BVMF:DXCO3 ), an important milestone in the...Articolo di analisi • May 04
Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a double-digit share price rise of over 10...Articolo di analisi • Apr 15
Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Articolo di analisi • Mar 14
Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem
Shareholders didn't seem to be thrilled with Dexco S.A.'s ( BVMF:DXCO3 ) recent earnings report, despite healthy profit...Articolo di analisi • Jan 19
Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors
With a price-to-earnings (or "P/E") ratio of 7.5x Dexco S.A. ( BVMF:DXCO3 ) may be sending bullish signals at the...Articolo di analisi • Jan 04
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Dec 04
At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?
Dexco S.A. ( BVMF:DXCO3 ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...Articolo di analisi • Oct 08
Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Articolo di analisi • Sep 13
Is Dexco (BVMF:DXCO3) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...AMMINISTRATORE DELEGATO
Raul Guaragna
no data
Mandato
Mr. Raul Guimaraes Guaragna is President & Chairman of the Board of Dexco S.A. Mr. Guaragna was VP, Director of Deca & Coatings Division and Member of Executive Board of Dexco S.A. Mr. Guaragna was Head of...
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman | 9.2yrs | Nessun dato | 0.038% R$ 1.7m | |
| Vice Chairman | 30.3yrs | Nessun dato | 0.74% R$ 33.2m | |
| Alternate Member | no data | Nessun dato | 0.71% R$ 31.8m | |
| Director | 18.1yrs | Nessun dato | 0.074% R$ 3.3m | |
| Vice Chairman | 9.2yrs | Nessun dato | Nessun dato | |
| Director | 5.3yrs | Nessun dato | 1.18% R$ 53.0m | |
| Substitute Member | 6yrs | Nessun dato | Nessun dato | |
| Independent Director | 6.3yrs | Nessun dato | Nessun dato | |
| Substitute Member | 5.3yrs | Nessun dato | Nessun dato | |
| Independent Director | no data | Nessun dato | Nessun dato | |
| Director | no data | Nessun dato | Nessun dato | |
| Independent Director | no data | Nessun dato | Nessun dato |
7.8yrs
Durata media
59.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di DXCO3 sono considerati esperti (durata media dell'incarico 7.8 anni).
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/22 12:54 |
| Prezzo dell'azione a fine giornata | 2026/05/21 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Dexco S.A. è coperta da 15 analisti. 10 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Guilherme Rosito | BofA Global Research |
| Rafael Barcellos | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Carlos Palhares Sequeira | BTG Pactual |